Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
Who we are:
Constructive Bio is a growing Cambridge based biotechnology company built on a simple conviction: the molecules that matter most are often the ones that can’t yet be made.
We’ve rewritten the genetic code to give cells access to new ncAA chemical building blocks - expanding the space of proteins that can be designed, engineered, and manufactured. Our platform moves from unexplored molecular territory to industrial-scale production, turning scientific possibility into manufacturable reality.
New MCP server connects external AI tools directly to structured laboratory data, with no exports or custom integrations required
· Suite of AI functions address key data bottlenecks in biological research labs, from protocol writing to equipment set-up
· The launch also marks Lab Thread's incorporation in the United States, extending support for the company's growing base of US life sciences customers
Contract Type Maternity Leave Cover, Fixed Term 12 Months
Working hours 37 hours per week
About Us
Babraham Research Campus is one of the UK's leading centres for bioscience innovation, bringing together world-class research, start-ups and growing biotech companies at the heart of the Cambridge life sciences cluster.
Qureight’s Fibr8 model to provide structural assessment as secondary endpoint in Contineum’s Phase 2 PROPEL-IPF clinical trial examining the safety and efficacy of PIPE-791 in idiopathic pulmonary fibrosis (IPF) patients
Read this season's news from One Nucleus and the wider ecosystem!
Guest post by Dmitry Bachin, PhD, Key Account Manager at SciSure | If you would like to submit a guest post please email [email protected]
Amsbio is a premier supplier of high-quality heparan sulfate (HS) monoclonal antibodies for use in brain and neurodegenerative research. In a recent published study** from Stanford University, these antibodies have been used to reveal a key role for endothelial glycocalyx degradation in aging and neurodegenerative disease.
Sandwich, UK — 4 November 2026: Discovery Park, Kent’s science and innovation hub, has launched the eighth edition of its Discovery Spark accelerator programme, welcoming 10 startups to its campus in Sandwich.